Quality of Life of Patients with Psoriasis: A Study of 54 Patients in Bamako
Download PDF


Quality of life



Submitted : 2023-05-08
Accepted : 2023-05-23
Published : 2023-06-07


Background: Psoriasis is a chronic recurrent inflammatory dermatosis occurring in genetically predisposed individuals. Its dramatic nature of the lesions, successive flare-ups, and skin discomfort may affect the quality of life of patients and result in a depressive tendency. Objective: To assess the impact of psoriasis on the quality of life of patients and the relationship between disease severity and quality of life. Methods: A descriptive cross-sectional study was carried out in Bamako from September 3, 2018 to August 30, 2019. The Dermatology Life Quality Index (DLQI) and Psoriasis Area Severity Index (PASI) were used to assess quality of life and factors of disease severity. Inclusion was based on clinical and histopathologic criteria. Questionable cases were excluded from the study. Results: A total of 106 cases of psoriasis were identified out of 24,000 consultations, i.e., a hospital frequency of 0.44%. Of these cases, 54 were included. Males accounted for 70% of the cases, and the average age was 37. The distribution of the social repercussions of the disease was as follows: disability (68.52%), non-participation in ceremonies (20.37%), stigmatization (18.52%), isolation (12.96%), work stoppage (11.11%), and non-sharing of meals (9.26%). However, the reception by caregivers was satisfactory in 96.30% of cases, and 85% of patients scored ≤ 10 on DLQI, suggesting that they had good quality of life. Among the patients with psoriasis, 35.04%, 12.96%, and 50.00% had mild, moderate, and severe disease, respectively. Conclusion: Quality of life is multifactorial and has no direct association with the severity of psoriasis. Dermatologists must take into account the dimensions of symptoms and psychological state when managing patients with psoriasis.


Kurd SK, Gelfand JM, 2009, The Prevalence of Previously Diagnosed and Undiagnosed Psoriasis in US Adults: Results from NHANES 2003–2004. Journal of the American Academy of Dermatology, 60(2): 218–224.

Dereure O, Guilhou JJ, 2003, Epidémiologie et Génétique du Psoriasis [Epidemiology and Genetics of Psoriasis]. Ann Dermatol Venereol, 130(8–9): 829–836.

Mbouopda NR, 2002, Aspects Épidémio-Cliniques et Thérapeutiques du Psoriasis à l’Institut Marchoux de 1990 à 1999 et de Novembre 1000 à Avril 2001 [Epidemiological and Therapeutic Aspects of Psoriasis at the Marchoux Institute from 1990 to 1999 and from November 1000 to April 2001]. Thèse Med Bamako, 2002: 132.

Schmutz JL, 2019, Psoriasis et Comorbidités [Psoriasis and Comorbidities], viewed on August 15, 2019, http://www.jim.fr

Dubertret L, 2009, Le Psoriasis 2ème Édition [Psoriasis 2nd Edition], MED COM, Paris, 155.

Garnier M, Delamare V, Delarmare J, et al., 2006, Dictionnaire Illustré des Termes de Médecine, 29ème Édition [Illustrated Dictionary of Medical Terms, 29th Edition], Maloine, Paris, 1048.

Finlay AY, Khan GK, 1994, Dermatology Life Quality Index (DLQI) – A Simple Practical Measure for Routine Clinical Use. Clin Exp Dermatol, 19(3): 210–216.

Finlay AY, 2005, Current Severe Psoriasis and the Rule of Tens. Br J Dermatol, 152(5): 861–867.

Finlay AY, 1997, Quality of Life Measurement in Dermatology: A Practical Guide. Br J Dermatol, 136(3): 305–314.

Mamadou K, Vagamon B, Isidore KY, et al., 2015, Psoriasis Among African Blacks: The Abidjan Experience of 17 Years. J Clin Exp Dermatol Res, 6(4): 1–3.

Ly F, 2013, Psoriasis sur Peaux Pigmentées [Psoriasis on Pigmented Skin]. Ann Dermatol Venereol, 140: S11–S12.

Ly F, Ndiaye M, Diatta M, et al., 2013, Aspects Épidémiologiques, Cliniques et Thérapeutiques du Psoriasis au Sénégal. A Propos de 295 Patients Suivis à la Clinique Dermatologique du CHU Aristide Le Dantec (1997–2011) [Epidemiological, Clinical and Therapeutic Aspects of Psoriasis in Senegal. A Follow-Up of 295 Patients at the Dermatological Clinic of Aristide Le Dantec University Hospital (1997–2011)]. Nouv Dermatol, 32: 5–7.

Barro/Traoré F Korsaga/Somé N, Kopa PY, et al., 2015, Aspects Épidémiologiques et Cliniques du Psoriasis à Ouagadougou [Epidemiological and Clinical Features of Psoriasis at Ouagadougou]. Dakar Med, 60(1): S11–S19.

Kassi K, Djeha D, Gbery IP, et al., 2016, Psoriasis in Elderly Patients in the Côte d’Ivoire: Socio-Demographic, Clinical, Therapeutic Aspects and Follow-Up. Int J Dermatol, 55(2): e83–e86.

Ndiaye M, 2010, Le psoriasis: Aspects Épidémiologiques, Cliniques et Thérapeutiques à Propos de 240 Patients Suivis à la Clinique Dermatologique du CHU Aristide Le Dantec (1997–2008) [Psoriasis: Epidemiological, Clinical and Therapeutic Aspects of 240 Patients Followed-Up at the Dermatological Clinic of Aristide Le Dantec University Hospital (1997–2008)]. Thèse Méd Dakar, 2010: 113.

Boisseau-Garsaud AM, Marie C, Garsaud P, et al., 1999, Epidémiologie du Psoriasis Dans Une Population Hospitalière Martiniquaise [Epidemiology of Psoriasis in a Martinican Hospital Population]. Ann Dermatol Venereol, 126(2s79): 213.

Salami TA, Samuel SO, Eze KC, et al., 2009, Prevalence and Characteristics of Aquagenic Pruritus in a Young African Population. BMC Dermatology, 9: 4.

Hagg D, Sundstrom A, Eriksson M, et al., 2015, Decision for Biological Treatment in Real Life Is More Strongly Associated with the Psoriasis Area and Severity Index (PASI) Than with the Dermatology Life Quality Index (DLQI). J Eur Acad Dermatol Venereol, 29(3): 452–456.

Attaqi K, 2017, Psoriasis et Qualité de Vie [Psoriasis and Quality of Life]. Thèse de Méd, Marrakech, 118.

Maoua M, El Maalel O, Boughattas W, et al., 2015, Qualité de Vie et Activité Professionnelle des Patients Atteints de Psoriasis au Centre Tunisien [Quality of Life and Professional Activity of Patients with Psoriasis in a Tunisian Center]. Archives des Maladies Professionnelles et de l'Environnement, 76(5): 439–448.

Lapeyre H, Hellot MF, Joly P, 2007, Motifs d’Hospitalisation des Malades Atteints de Psoriasis [Reasons for Hospitalization of Patients with Psoriasis]. Ann Dermatol Venereol, 134(5): 433–436.

Wu C-Y, Hu H-Y, Li C-P, et al., 2018, Comorbidity Profiles of Psoriasis in Taiwan: A Latent Class Analysis. PLoS ONE, 13(2): e0192537.

Dalgard FJ, Gieler U, Tomas-Aragones L, et al., 2015, The Psychological Burden of Skin Diseases: A Cross-Sectional Multicenter Study Among Dermatological Out-Patients in 13 European Countries. J Invest Dermatol, 135(4): 984–991.

Dioussé P, Ndiaye M, Diatta BA, et al., 2013, Profil Épidémiologique, Clinique et Évolutif du Psoriasis dans la Région de Thiès au Sénégal [Epidemiological, Clinical and Evolutionary Profile of Psoriasis in the Region of Thi`es in Senegal]. Dakar Med, 60(1): 26–30.